Primmos CLC385 variant hemoglobin test group - Taiwan Registration 6142d2b631b676d3d2e5e4262e8230df
Access comprehensive regulatory information for Primmos CLC385 variant hemoglobin test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6142d2b631b676d3d2e5e4262e8230df and manufactured by Trinity Biotech (Primus Corporation dba Trinity Biotech). The authorized representative in Taiwan is PROGRESSIVE GROUP INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
High-pressure liquid chromatography is used for in vitro diagnosis of whole blood or diluted specimens to quantify the variant hemoglobin of normal people or patients.
B Hematology, pathology, and genetics
B.7415 Abnormal hemoglobin analysis
import
Dates and Status
Feb 10, 2006
Feb 10, 2021
Sep 19, 2023
Cancellation Information
Logged out
่ช่ก้ตๅ ฅ